Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiltronic Share News (FTC)

Share Price Information for Filtronic (FTC)

Share Price is delayed by 15 minutes
Get Live Data
357.50    14.00 (4.29%)
Bid:
355.00
Ask:
360.00
Spread: 5.00 (1.408%)
Market Cap: £747.81m
FTC Live PriceLast checked at - London Stock Exchange

Intraday Filtronic Share Chart

TechMARK movers: Antisoma drug shock

Mon, 31st Jan 2011 12:26
Antisoma has lost nearly two-thirds of its value after its phase III trial for the AS1413 treatment for secondary acute myeloid leukaemia showed the drug to be ineffective. The data published from the trial shows that the drug is no better than the current standard and the drug is being dropped. Antisoma has also ended its phase II trial for leukaemia drug AS1411, which also appears ineffective. Broker Peel Hunt reckons that Antisoma has 3.5p a share in cash but expects that to fall to 2p a share - around the present share price. Peel Hunt sees little future for Antisoma as it has few other assets. Communications equipment supplier Filtronic has reported higher interim revenues but also a higher operating loss. Panmure Gordon has cut its revenue forecast for the year to May 2011 by £1.5m to £18.5m because of the uncertainty caused by the new ownership of important customer Nera. The broker also expects a higher loss. Electronic components manufacturer e2v Technologies says that trading since the end of September 2010 has been ahead of expectations. That means that the performance to March 2011 should be better than expected. Trading has been much better than the previous year. The order book for the next 12 months is worth £143m, up £38m on the end of 2009 figure. The total order book is flat at £166m. Net debt was down to £33m at the end of 2010 and the March 2011 figure will be lower than originally forecast. FTSE TechMARK - Risers Ceva Inc. (CVA) 1,350.00p +8.00%Sepura (SEPU) 50.00p +4.71%E2V Technologies (E2V) 111.00p +4.23%Ricardo (RCDO) 335.00p +3.08%Misys (MSY) 332.80p +2.09%Fidessa Group (FDSA) 1,561.00p +1.36%Asterand (ATD) 19.75p +1.28%Psion (PON) 93.75p +0.81%Corin Group (CRG) 48.50p +0.52%ProStrakan Group (PSK) 101.00p +0.50%FTSE TechMARK - Fallers Antisoma (ASM) 2.11p -66.24%Filtronic (FTC) 34.00p -18.07%Vernalis (VER) 47.00p -3.59%Optos (OPTS) 190.00p -3.31%Emblaze Ltd. (BLZ) 42.00p -2.89%Imagination Technologies Group (IMG) 358.90p -2.61%Oxford Biomedica (OXB) 5.65p -2.08%XP Power Ltd. (DI) (XPP) 1,361.00p -1.73%KCOM Group (KCOM) 57.75p -1.70%RM (RM.) 167.00p -1.47%

Related News

Kelso says portfolio value rises in May as backs Capita turnaround
22 hours ago

Kelso says portfolio value rises in May as backs Capita turnaround

(Alliance News) - Kelso Group Holdings PLC on Friday said it has bought shares in Capita PLC in recent weeks, as the London-based investor in UK liste...

WINNERS & LOSERS: Marechale rallies on digital bank plan; boohoo jumps
2 days ago

WINNERS & LOSERS: Marechale rallies on digital bank plan; boohoo jumps

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.

WINNERS & LOSERS: Creo Medical jumps; Hercules resumes trading
22 May 2026

WINNERS & LOSERS: Creo Medical jumps; Hercules resumes trading

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.

Filtronic News

Kelso says portfolio value rises in May as backs Capita turnaround
22 hours ago

Kelso says portfolio value rises in May as backs Capita turnaround

(Alliance News) - Kelso Group Holdings PLC on Friday said it has bought shares in Capita PLC in recent weeks, as the London-based investor in UK liste...

WINNERS & LOSERS: Marechale rallies on digital bank plan; boohoo jumps
2 days ago

WINNERS & LOSERS: Marechale rallies on digital bank plan; boohoo jumps

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.

WINNERS & LOSERS: Creo Medical jumps; Hercules resumes trading
22 May 2026

WINNERS & LOSERS: Creo Medical jumps; Hercules resumes trading

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.

WINNERS & LOSERS: Altona snaps share price fall; Colefax profit climbs
8 May 2026

WINNERS & LOSERS: Altona snaps share price fall; Colefax profit climbs

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.

WINNERS & LOSERS: RWS unveils deal; Gulf Marine wins contracs
5 May 2026

WINNERS & LOSERS: RWS unveils deal; Gulf Marine wins contracs

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.

LONDON BROKER RATINGS: Exane BNP initiates coverage; UBS cuts SSP
28 Apr 2026

LONDON BROKER RATINGS: Exane BNP initiates coverage; UBS cuts SSP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

Kelso says Filtronic investment value rises to 10% of portfolio
27 Apr 2026

Kelso says Filtronic investment value rises to 10% of portfolio

(Alliance News) - Kelso Group Holdings PLC on Monday reported a new significant holding in Filtronic PLC.

LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling
27 Apr 2026

LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling

(Alliance News) - GSK reports on a US court ruling in ongoing litigation, AstraZeneca announces US approval for a self-administered lupus treatment, w...